Literature DB >> 10457585

Immune mechanisms in uveitis.

R R Caspi1.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10457585     DOI： 10.1007/bf00810244

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  56 in total

1.  Thymic expression of autoantigens correlates with resistance to autoimmune disease.

Authors:  C E Egwuagu; P Charukamnoetkanok; I Gery
Journal:  J Immunol       Date:  1997-10-01       Impact factor: 5.422

Review 2.  Th1 and Th2 subsets: paradigms lost?

Authors:  A Kelso
Journal:  Immunol Today       Date:  1995-08

3.  Experimental autoimmune uveoretinitis in mice. Induction by a single eliciting event and dependence on quantitative parameters of immunization.

Authors:  R R Caspi; C C Chan; W C Leake; M Higuchi; B Wiggert; G J Chader
Journal:  J Autoimmun       Date:  1990-06       Impact factor: 7.094

4.  Genetic susceptibility to experimental autoimmune uveitis involves more than a predisposition to generate a T helper-1-like or a T helper-2-like response.

Authors:  B Sun; L V Rizzo; S H Sun; C C Chan; B Wiggert; R L Wilder; R R Caspi
Journal:  J Immunol       Date:  1997-07-15       Impact factor: 5.422

5.  T cell traffic and the inflammatory response in experimental autoimmune uveoretinitis.

Authors:  R A Prendergast; C E Iliff; N M Coskuncan; R R Caspi; G Sartani; T K Tarrant; G A Lutty; D S McLeod
Journal:  Invest Ophthalmol Vis Sci       Date:  1998-04       Impact factor: 4.799

6.  Role of Th1 and Th2 cells in anterior chamber-associated immune deviation.

Authors:  X Y Li; L T D'Orazio; J Y Niederkorn
Journal:  Immunology       Date:  1996-09       Impact factor: 7.397

7.  Monoclonal antibodies against ICAM-1 (CD54) and LFA-1 (CD11a/CD18) inhibit experimental autoimmune uveitis.

Authors:  S M Whitcup; L R DeBarge; R R Caspi; R Harning; R B Nussenblatt; C C Chan
Journal:  Clin Immunol Immunopathol       Date:  1993-05

8.  Interleukin-2 treatment potentiates induction of oral tolerance in a murine model of autoimmunity.

Authors:  L V Rizzo; N E Miller-Rivero; C C Chan; B Wiggert; R B Nussenblatt; R R Caspi
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

9.  Orally induced bystander suppression in experimental autoimmune uveoretinitis occurs only in the periphery and not in the eye.

Authors:  G Wildner; S R Thurau
Journal:  Eur J Immunol       Date:  1995-05       Impact factor: 5.532

10.  Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease.

Authors:  J J Lafaille; F V Keere; A L Hsu; J L Baron; W Haas; C S Raine; S Tonegawa
Journal:  J Exp Med       Date:  1997-07-21       Impact factor: 14.307
View more
  30 in total

1.  Gene expression profiling in autoimmune noninfectious uveitis disease.

Authors:  Zhuqing Li; Baoying Liu; Arvydas Maminishkis; Sankaranarayana P Mahesh; Steven Yeh; Julie Lew; Wee Kiak Lim; H Nida Sen; Grace Clarke; Ronald Buggage; Sheldon S Miller; Robert B Nussenblatt
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

2.  Spontaneous retinopathy in HLA-A29 transgenic mice.

Authors:  Y Szpak; J C Vieville; T Tabary; M C Naud; M Chopin; C Edelson; J H Cohen; J Dausset; Y de Kozak; M Pla
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

Review 3.  Biologic agents in experimental autoimmune uveitis.

Authors:  Gian Paolo Giuliari; Ama Sadaka; David M Hinkle
Journal:  Int Ophthalmol       Date:  2013-03-14       Impact factor: 2.031

4.  Role of DAF in protecting against T-cell autoreactivity that leads to experimental autoimmune uveitis.

Authors:  Fengqi An; Qing Li; Zhidan Tu; Hong Bu; Chi-Chao Chan; Rachel R Caspi; Feng Lin
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-05-14       Impact factor: 4.799

Review 5.  Regulation, counter-regulation, and immunotherapy of autoimmune responses to immunologically privileged retinal antigens.

Authors:  Rachel R Caspi
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

6.  Hydrodynamic vaccination with DNA encoding an immunologically privileged retinal antigen protects from autoimmunity through induction of regulatory T cells.

Authors:  Phyllis B Silver; Rajeev K Agarwal; Shao-Bo Su; Isabelle Suffia; Rafael S Grajewski; Dror Luger; Chi-Chao Chan; Rashid M Mahdi; John M Nickerson; Rachel R Caspi
Journal:  J Immunol       Date:  2007-10-15       Impact factor: 5.422

7.  Ocular regulatory T cells distinguish monophasic from recurrent autoimmune uveitis.

Authors:  Yan Ke; Guomin Jiang; Deming Sun; Henry J Kaplan; Hui Shao
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-05-16       Impact factor: 4.799

8.  Inhibitory peptide analogs derived from a major uveitogenic epitope protect from antiretinal autoimmunity by inducing type 2 and regulatory T cells.

Authors:  Lizette M Cortes; Dody Avichezer; Phyllis B Silver; Dror Luger; Mary J Mattapallil; Chi-Chao Chan; Rachel R Caspi
Journal:  J Leukoc Biol       Date:  2008-05-21       Impact factor: 4.962

9.  Repertoire analysis and new pathogenic epitopes of IRBP in C57BL/6 (H-2b) and B10.RIII (H-2r) mice.

Authors:  Lizette M Cortes; Mary J Mattapallil; Phyllis B Silver; Larry A Donoso; Gregory I Liou; Wei Zhu; Chi-Chao Chan; Rachel R Caspi
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-05       Impact factor: 4.799

10.  Vorinostat Modulates the Imbalance of T Cell Subsets, Suppresses Macrophage Activity, and Ameliorates Experimental Autoimmune Uveoretinitis.

Authors:  Sijie Fang; Xiangda Meng; Zhuhong Zhang; Yang Wang; Yuanyuan Liu; Caiyun You; Hua Yan
Journal:  Neuromolecular Med       Date:  2016-01-21       Impact factor: 3.843
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.